BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2013
View Archived Issues
Taiho presents results from animal studies of TAS-204 in allergic diseases
Read More
AM-679 inhibits early capillary degeneration in vivo
Read More
GSK-2330672 demonstrates significant effects on bile acid excretion and synthesis in phase I trial
Read More
Oral CCX-872 is well tolerated in healthy volunteers
Read More
Phase I results demonstrate intravenous LBR-101 to be safe and well tolerated
Read More
Eisai reports first clinical data for anti-protofibrilar monoclonal antibody BAN-2401
Read More
Novartis reflects on accomplishments of second quarter 2013
Read More
Alleanza begins recruitment in pilot study comparing ALZ-1101 to latanoprost
Read More
Janssen R&D Ireland prepares and tests novel HCV inhibitors
Read More
Reviva Pharmaceuticals describes monoamine transporter inhibitors
Read More
HDAC8 inhibitors reported in recent Pharmacyclics patent
Read More
French group patents K(2P)2.1 activators for pain
Read More
Invion initiates phase II trial of INV-103 in lupus
Read More
Chiesi Farmaceutici patent reports development of muscarinic M3 receptor antagonists
Read More
FDA and EMA accept Plegridy marketing applications for review
Read More
RaQualia and Eli Lilly to further extend the research term of the collaboration
Read More
FDA approves Astagraf XL for organ transplant rejection
Read More
Synairgen reports biomarker data from phase II study of SNG-001
Read More
Phase II study of GDC-0068 under way in gastroesophageal junction cancer
Read More
Amphivena Therapeutics completes financing and signs agreement with Janssen
Read More
Researchers create zebrafish model of pharmacoresistant epilepsy
Read More
Grant supports microRNA work by InteRNA's collaborator UMC St. Radboud
Read More
Heptares achieves research milestone in GPCR collaboration with Cubist
Read More
Centaurus BioPharma patents novel SERMs
Read More